Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
5
Neutral
4
Bullish
5
Bearish
37
Neutral
4
Bullish
5
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Investor Presentation
Q2 FY25
Discovery themes featuring this stockBhagiradha Chemicals & Industries Ltd (BHAGCHEM) is currently trading at 196.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Bhagiradha Chemicals and Industries Limited is an India‑based specialty agrochemical company (founded 1993) that develops, manufactures and sells active ingredients, intermediates and formulations through its Ongole plant and the Bheema Fine Chemicals subsidiary, with aggregate manufacturing capacity expanding from 3,250 MT to a proposed 9,002 MT at the new Karnataka facility. Q1 FY27 delivered the company’s highest ever quarterly performance: revenue of Rs.195.0 crore (up 58% YoY), gross margin expanded to 38.6%, EBITDA Rs.30.5 crore (15.7% margin) and PAT Rs.13.3 crore, driven by higher volumes, improved realizations, new molecule launches and stronger product mix despite higher depreciation and finance costs from the Bheema ramp‑up. Bheema Fine Chemicals is a transformational growth engine: Phase 1A capex ~Rs.39 crore is complete, Phase 1B ~Rs.411 crore has commenced with a 12–24 month ramp profile, and Phase 2 of ~Rs.400 crore is planned for Q2 FY28, positioning Bhagiradha to introduce 6–10 additional high‑value actives and materially expand addressable markets and global customer relationships. R&D and backward integration are core strategic priorities: Bhagiradha has eight synthesis labs with 100+ chemists, pilot and semi‑commercial plants, a library of 120+ reactions, and a roadmap to increase backward integration to N‑9 by FY27, enabling faster launch of complex, mid‑ and high‑value molecules and improved margin capture via non‑infringing, cost‑efficient processes. Sustainability and compliance are emphasized: the Ongole facility operates a Zero Liquid Discharge effluent treatment system, a 4 MW solar plant, electro‑oxidation treatment, and regular safety and groundwater audits, supporting export credibility in regulated markets and customer validation for environmentally responsible manufacturing.
Over the past 52 weeks, Bhagiradha Chemicals & Industries Ltd has traded between a low of ₹170.00 and a high of ₹315.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Bhagiradha Chemicals & Industries Ltd has a market capitalization of approximately 2,580.41. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Bhagiradha Chemicals & Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 93.87 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 2,580.41 Cr, Bhagiradha Chemicals & Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Bhagiradha Chemicals & Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Bhagiradha Chemicals & Industries Ltd is 93.87. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bhagiradha Chemicals and Industries Limited is an India‑based specialty agrochemical company (founded 1993) that develops, manufactures and sells active ingredients, intermediates and formulations through its Ongole plant and the Bheema Fine Chemicals subsidiary, with aggregate manufacturing capacity expanding from 3,250 MT to a proposed 9,002 MT at the new Karnataka facility.
Q1 FY27 delivered the company’s highest ever quarterly performance: revenue of Rs.195.0 crore (up 58% YoY), gross margin expanded to 38.6%, EBITDA Rs.30.5 crore (15.7% margin) and PAT Rs.13.3 crore, driven by higher volumes, improved realizations, new molecule launches and stronger product mix despite higher depreciation and finance costs from the Bheema ramp‑up.
Bheema Fine Chemicals is a transformational growth engine: Phase 1A capex ~Rs.39 crore is complete, Phase 1B ~Rs.411 crore has commenced with a 12–24 month ramp profile, and Phase 2 of ~Rs.400 crore is planned for Q2 FY28, positioning Bhagiradha to introduce 6–10 additional high‑value actives and materially expand addressable markets and global customer relationships.
R&D and backward integration are core strategic priorities: Bhagiradha has eight synthesis labs with 100+ chemists, pilot and semi‑commercial plants, a library of 120+ reactions, and a roadmap to increase backward integration to N‑9 by FY27, enabling faster launch of complex, mid‑ and high‑value molecules and improved margin capture via non‑infringing, cost‑efficient processes.
Sustainability and compliance are emphasized: the Ongole facility operates a Zero Liquid Discharge effluent treatment system, a 4 MW solar plant, electro‑oxidation treatment, and regular safety and groundwater audits, supporting export credibility in regulated markets and customer validation for environmentally responsible manufacturing.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
2,542 Cr
Moderate Risk
92.5
18.4
0.7
3.7
315.90
170.00
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Nov 02, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
183.90 | 3,691 Cr | 17.97 | 1.68 | 1.58 | 8.99 | 11.91 | 5.74 | ||
110.65 | 2,710 Cr | 104.23 | 3.97 | 0.00 | 2.49 | 7.39 | 0.91 | ||
196.00 | 2,580 Cr | 93.87 | 3.70 | 0.08 | 2.60 | 4.13 | 2.46 | ||
932.00 | 1,578 Cr | 10.79 | 1.24 | 0.05 | 11.43 | 15.51 | 10.00 | ||
519.80 | 1,487 Cr | 11.88 | 1.22 | 0.39 | 11.42 | 14.78 | 6.26 | ||
52.43 | 1,395 Cr | 21.68 | 0.90 | 0.00 | 1.86 | 6.75 | 2.13 | ||
112.90 | 1,346 Cr | 12.50 | 1.33 | 0.64 | 11.86 | 15.46 | 8.06 | ||
| Median: 7 Co. | — | 183.90 | 1,578 Cr | 17.97 | 1.33 | 0.08 | 8.99 | 11.91 | 5.74 |
